Biotech funds

SF-based venture capital firm investing in science and technology companies solving difficult problems. The firm invests at all stages across a wide variety of sectors. Founders Fund pursues a founder-friendly investment strategy, providing maximum support with minimum interference.

Partnership and distributed network that is agile, diversified, and market-tested led by Hank Vigil. They are at the center of a global ecosystem that attracts and fuels the technical founders and product teams building the next wave of global businesses.

Fund based in London, San Francisco and Geneva, helping entrepreneurs turn bold ideas into transformative international businesses. Index covers every investment stage, from earliest seed through to explosive growth.

Founded by Dr. Ling Wong to fund companies using science and tech to build a better future

Thesis-driven earliest-stage venture capital firm built by founders, experienced operators, nerds, and dreamers obsessed with the future. Their core thesis is that platform companies will deliver outsized, venture-scale returns. Currently investing out of their $67M Fund II.

Boston venture capital firm that supports founders with early-stage and seed VC funding, investing in their professional & personal growth.

Backs bold entrepreneurs building the future through technology.

$50M seed-stage operator fund led by Raymond Tonsing. Thesis and stage agnostic firm. They typically partner with founders at the inception stage and invest throughout the life of the company.

Investing in former science projects with a thesis-driven approach.

$10m Fund that invests in companies building in the Web3, AI, and Deep Science space that can generate massive wealth through the creation of structures that are more equitable, beneficial, transparent, and accessible.

BlueYard backs founders building the interconnected elements that can become the fabric of our future. Read more about BlueYard on Medium: https://blueyard.medium.com/

Founded by Packy McCormick of the Not Boring newsletter, Not Boring Capital is on a mission to help founders tell their stories, and make the world more optimistic

Backs entrepreneurs using Deep Tech to solve problems and multiply the benefits of capitalism for everyone while reducing its cost

OS Fund is founded by Bryan Johnson, founder of Braintree (the creator of Venmo) to support inventors and scientists who aim to benefit humanity by rewriting the operating systems of life The firm believes biology is programmable, and invests in platforms and enabling technologies (i.e. Ginkgo Bioworks).

Technology and life sciences investment firm that builds and invests in the world’s most ambitious companies. 8VC partners with elite founders to build transformational technologies that create long-term economic and societal value.

Broadly, a venture we back offers one or more of the factors: 1. Significant technology or business model innovation 2. “Black Swan” ideas with significant upside or a significantly better mousetrap 3. Large markets, either existing or newly enabled by the innovation at hand 4. Short innovation cycles 5. Upfront risk

Kleiner Perkins was founded in the 1970s by Tom Perkins and Eugene Kleiner. The firm is focused on early-stage digital consumer and enterprise, green tech and life sciences companies.

Invests in founders who don't fit the mold - those entrepreneurs who ascribe to our "Third Culture" principles because of their unique life experiences. They are global by design but admit they could add the most value if for example, you are an ex-US company with tangible plans for a US launch.

With more than 135 IPOs and 200 portfolio companies in the enterprise, consumer and healthcare spaces, Bessemer supports founders and CEOs from their early days through every stage of growth. Bessemer’s global portfolio has included Pinterest, Shopify, Twilio, Yelp, LinkedIn, PagerDuty, DocuSign, Wix, Fiverr and Toast and has more than $20 billion of assets under management.

Founded in 1987, Canaan is a long-time early-stage investor currently investing out of their 12th Fund ($800M).

Global venture capital firm investing in technology and healthcare

ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. 

Early-stage partners in helping founders build their companies. AV8 is backed by Allianz, one of the leading integrated financial services providers worldwide.

Believes that creating something of true significance starts with seeing things others do not.

46 year old VC firm with >$5bn AUM investing in innovation-driven companies.

No project is too early for Wing. They invest early, before it's obvious, often before product or revenue. They also put substantial capital and strategic resources into each company throughout its lifecycle.

The GPs started companies themselves to develop new technologies, and they want to help more technical founders do the same. That's why they invest in the early stage, giving their voting rights back to the founding teams. They also run the SciFounder Fellowship, a mentorship program for idea-stage founders with a $400,000 investment.

Invests in AI-first technology and life science companies as early as possible and enjoy iterating through product, market, and technology strategy from day 1.

Invests in solutions to complex problems in human and animal health.

Focused on pre-seed deep technology startups building around differentiated IP

Believes that iconic companies transcend boundaries: they can be built anywhere, by anyone, and in any corner of the economy, from curing rare diseases at scale to powering global payments for organizations of all sizes. They partner with founders around the world, across sectors, and at various stages, primarily before success is obvious.

Launched as Google Ventures in 2009, GV originated as an independent venture capital firm for innovative founders. With Alphabet as their sole limited partner, they focus all our energy on meeting and supporting founders at the earliest stages of company-building.

For over  25 years, Insight Partners has helped over 600 companies turn their vision into reality. They invest and support founders from seed until the later stages.

Partners with companies and founders trying to change the world, who want to upend paradigms, not just chase incremental progress. Over the past two decades, Lux has expanded from their New York City roots to Silicon Valley, and built a $4 billion AUM firm of more than 30 full-time professionals, with a wide spectrum of technical backgrounds and the versatility to invest at any stage.

Led by the founders of Flatiron Health (acquired by Roche). They prefer to invest alongside a lead VC check (and if there's no lead yet, they'll help the founder find one).

Invests in breakthrough scientific startups.

Helps the daring build legendary companies, from idea to IPO and beyond.

Invests in the brilliant people who bring ideas that matter to life. Founded in 2005, True Ventures has already invested $3.8B across 350+ teams.

True Ventures will only enter on the initial round of capital but will have reserves and continue to follow on in their existing portfolio. They target 20% + ownership on the initial investment.

Climate Capital is an early-stage climate tech VC with over 250+ portfolios across various sectors working on decarbonizing the global economy.

Their due diligence process starts with a few calls with the team, then a review of the deck and data room. It takes 2-4 weeks from first call to sign and wire.
They do not engage until after the lead is in place.

Climate Capital has a slack community of with our 250+ founders to share knowledge and resource. They also have a bunch of discounts through builtfirst and other vendors on software tools. They have a blog series to help promote our companies

Led by Skype founder Jaan Tallinn, Metaplanet invests in novel and evidence-based innovation that could produce an outsized return for the benefit of humankind.

Obsessively pursuing the near frontier, where software, hardware, & wetware intersect.

Backs mission-driven founders leveraging science and technology in service of achieving the UN’s Sustainable Development Goals.

Early-stage, multi-thematic firm investing in purpose-driven founders reimagining the building blocks of life and society.

Founded by former Google CEO Eric Schmidt. Invests in mission-driven founders, transformational technologies, and emergent ecosystems. The firm’s central investment thesis, the Super Evolution, combines data, leading-edge computation, and advanced engineering to transform various industries including the life sciences, agriculture, supply chain, and more.

$50M Fund investing in seed-stage companies that deploy technology to enhance planetary and human health by radically upending traditionally regulated industries.

Specializes in helping extraordinary seed-stage founders on a mission to improve the health of people and planet.

Invests in creative bioscience companies harnessing the power of cells and computation to scale solutions in human health and sustainability.

Partners with entrepreneurs solving real-world problems using data and machine learning, focusing on applications of frontier technologies such as AI, computational biotech, connected sensors, AR/VR, and blockchain.

A venture fund building deep tech companies powered by material science innovations

Investing in technical founders at the earliest stages solving the biggest challenges facing our world.

Invests in deeply technical, under-networked founders trying to build their companies

Backing entrepreneurs using technology to solve the world's biggest problems.

Finance-first social impact VC

Exclusively focused on AI, employing a builder's mindset. Innospark is a curious, rigorous, and thoughtful partner, investing their own capital.

Early-stage venture capital firm founded by entrepreneurs and operators who've built companies cumulatively worth $300 billion. GreatPoint's mission is to partner with entrepreneurs solving big problems across enterprise, healthcare, bio-tech, and food. In order to have time to fight in the trenches with every team they back, they make fewer than 10 new investments per year.

Venture capital partnership investing in early-stage healthcare and life sciences companies. They usually invest in the first or second institutional round of financing that a company raises, and typically before companies have reached a $100mm valuation.

Pebblebed invests in early-stage companies with profound technical insight as its differentiator. They like to back businesses that build long-term moats, like end-user stickiness, brand, or high switching costs.

Invests in early-stage companies that synthesize engineering with physical and life sciences to create technologies that disrupt global conventions to solve critical issues of our time

Engages founders working on the frontiers of science and technology with the potential to solve some of the most pressing challenges we face in the world today.

Backs founders at the forefront of innovation with a clear vision toward positive change, and they leverage our domain expertise to ensure value creation.

First In Ventures is a venture capital firm based in Middletown, Delaware. The firm seeks to invest in early stage biotech and life sciences companies.

Built by experienced Life Science founders to support early-stage Life Science startups engineering biology to drive radical advances in human health

Values emotional intelligence as much as data, growing internal culture as much as growing revenue, and forming strong, personal bonds with founders.

Sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for its shareholder, the Government of Abu Dhabi.

Founded by Color co-founder Nish Bhat, Carbon Silicon Ventures is a new fund backing founders applying engineering & scale to biology & Healthcare

Aims to support early-stage companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Founded over 25 years ago, Delphi Ventures is one of the first venture capital firms to focus on investing in life sciences companies

SF-based VC firm built by pioneers within TechBio to invest at the intersection of technology and biology and healthcare. 

Early-stage firm investing in science companies working at the intersection of artificial intelligence and automation

Invests in digital health companies enabling new care delivery models or more efficient therapeutic development.

Northpond Ventures is a science-driven project capital firm that focuses on biotechnology and affiliated industries

Venture Capital fund specializing in early-stage, B2B software companies on the East Coast.

Invests in early-stage life sciences companies often when they are no more than an idea

Helps founders and their companies re-architect the world at a molecular level.

Early-stage VC firm investing in big ideas and breakthrough discoveries.

Global VC firm focusing on inception and early-stage investing in tech.

Founded in 2002, +ND invests in disruptive technologies across the life, physical, and data sciences. The fund's core belief is that scientific disciplines will continue to converge and that some of the biggest breakthroughs will be based on this convergence.

Makes long-term concentrated investments in founders who are capable of growing with their companies and maximizing impact over a period of decades. Sector, geography, and stage agnostic.

$150M technology-focused venture fund based in Los Altos, California making investments in early-stage startups across software, life science, and deep tech.

$37M Seed and Series A fund investing in founders developing therapeutic breakthroughs for age-related disease.

Invests their own capital and supports entrepreneurs across their entire journey from napkin to IPO. BoxOne likes partnering in the earliest days and bringing our experience as founders to support entrepreneurs while making sure to never get in their way.

Invests in healthcare and technology in the US and Europe Funded in 1946 and have over $2T in assets managed.

Focused on cutting edge innovations in exponential health tech and biology

Focused on technologies that extend the boundaries of human performance

A first-of-its-kind fund partnering with founders at the interface of technology and life sciences to transform the trajectory of life on earth

They are currently investing through Dimension 1; a $350M fund investing at the earliest stages - incubation through growth - of drug discovery platforms, machine learning, tools, services, instruments & software companies digitizing the world of life sciences